Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Rejnmark

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
Calcified Tissue International|August 24, 2006
Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fractureP Vestergaard, L Rejnmark, L Mosekilde
Journal of Internal Medicine|March 25, 2005
Fracture risk associated with systemic and topical corticosteroidsP Vestergaard, L Rejnmark, L Mosekilde
Calcified Tissue International|July 12, 2005
Reduced relative risk of fractures among users of lithiumP Vestergaard, L Rejnmark, L Mosekilde
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 10, 2006
Fracture risk in patients treated with amiodarone or digoxin for cardiac arrhythmias: a nation-wide case-control studyL Rejnmark, P Vestergaard, L Mosekilde
Calcified Tissue International|July 27, 2006
Statin but not non-statin lipid-lowering drugs decrease fracture risk: a nation-wide case-control studyL Rejnmark, P Vestergaard, L Mosekilde
Calcified Tissue International|August 24, 2006
Methotrexate, azathioprine, cyclosporine, and risk of fractureP Vestergaard, L Rejnmark, L Mosekilde
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 15, 2007
Increased mortality in patients with a hip fracture-effect of pre-morbid conditions and post-fracture complicationsP Vestergaard, L Rejnmark, L Mosekilde
Calcified Tissue International|September 10, 2005
Influence of hyper- and hypothyroidism, and the effects of treatment with antithyroid drugs and levothyroxine on fracture riskP Vestergaard, L Rejnmark, L Mosekilde
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 28, 2012
PTH replacement therapy of hypoparathyroidismL Rejnmark, T Sikjaer, L Underbjerg, et al.
Thyroid : Official Journal of the American Thyroid Association|May 12, 2000
Fracture risk in patients treated for hyperthyroidismP Vestergaard, L Rejnmark, J Weeke, et al.
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Calcified Tissue International|August 24, 2006
Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fractureP Vestergaard, L Rejnmark, L Mosekilde
Journal of Internal Medicine|March 25, 2005
Fracture risk associated with systemic and topical corticosteroidsP Vestergaard, L Rejnmark, L Mosekilde
Calcified Tissue International|July 12, 2005
Reduced relative risk of fractures among users of lithiumP Vestergaard, L Rejnmark, L Mosekilde
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 10, 2006
Fracture risk in patients treated with amiodarone or digoxin for cardiac arrhythmias: a nation-wide case-control studyL Rejnmark, P Vestergaard, L Mosekilde
Calcified Tissue International|July 27, 2006
Statin but not non-statin lipid-lowering drugs decrease fracture risk: a nation-wide case-control studyL Rejnmark, P Vestergaard, L Mosekilde
Calcified Tissue International|August 24, 2006
Methotrexate, azathioprine, cyclosporine, and risk of fractureP Vestergaard, L Rejnmark, L Mosekilde
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 15, 2007
Increased mortality in patients with a hip fracture-effect of pre-morbid conditions and post-fracture complicationsP Vestergaard, L Rejnmark, L Mosekilde
Calcified Tissue International|September 10, 2005
Influence of hyper- and hypothyroidism, and the effects of treatment with antithyroid drugs and levothyroxine on fracture riskP Vestergaard, L Rejnmark, L Mosekilde
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 28, 2012
PTH replacement therapy of hypoparathyroidismL Rejnmark, T Sikjaer, L Underbjerg, et al.
Thyroid : Official Journal of the American Thyroid Association|May 12, 2000
Fracture risk in patients treated for hyperthyroidismP Vestergaard, L Rejnmark, J Weeke, et al.
Pageof 7